Biogen Idec (Nasdaq: BIIB)has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE